📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Late Treatment With Autologous Expanded Regulatory T-cell Therapy After Alemtuzumab Induction Is Safe and Facilitates Immunosuppression Minimization in Living Donor Renal Transplantation. (2024)

First Author: Brook MO

Attributed to: University of Oxford Confidence in Concept – Round 7 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1097/tp.0000000000005065

PubMed Identifier: 38845088

Publication URI: http://europepmc.org/abstract/MED/38845088

Type: Journal Article/Review

Volume: 108

Parent Publication: Transplantation

Issue: 11

ISSN: 0041-1337